CalciMedica, Inc. — Form 8-K
Filed September 30, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 76/100
What the filing says
CalciMedica, Inc. (Delaware corporation) filed a prospectus supplement on September 30, 2026, registering up to 25,000,000 shares of common stock (par value $0.0001/share) for sale under an At the Market (ATM) Offering Agreement with H.C. Wainwright Co., LLC dated August 11, 2023. The aggregate offering price is up to $25,000,000. This is a standard legal opinion letter confirming the shares will be validly issued, fully paid, and nonassessable under Delaware law.
Why this rating
$25M ATM offering is 159% of company's $15.7M market cap—potentially substantial dilution and capital raise relative to size. However, legal opinion alone does not confirm execution or pricing terms; offering is registered but not yet fully deployed. Significant financing event for small-cap company.
Price action (we called it neutral)
before filing · preread $1.60 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.